Anti-inflammatory glycosides from plants: Identification of cellular targets and examination of structure–function relationships
Anti-inflammatory glycosides from plants: Identification of cellular targets and examination of structure–function relationships
批准号:
407666933
负责人:
Professor Dr. Hendrik Fuchs
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2022-12-31
中文摘要
植物糖苷的独特多样性为开发天然药物提供了巨大的潜力。过去,我们专注于鉴定糖基化三萜在靶向肿瘤治疗中的内体逃逸增强剂。我们从皂角草(Saponaria officinalis L.)中鉴定出一种特殊的皂苷SO1861,并在细胞培养中证明,肿瘤靶向毒素的细胞杀伤效率可提高至250万倍,这使小鼠的治疗窗口扩大了10倍至500倍。在所有小鼠研究中,肿瘤消退约为90%,所需剂量仅为不含SO1861的治疗剂量的2%。较低的剂量导致副作用减少和免疫原性降低。我们证明了增强效应依赖于毒素部分通过内吞囊泡膜进入细胞质的增强转移。需要强调的是,SO1861的这种特殊结果发生在远低于触发一般皂苷效应(如溶血)所需的浓度的情况下,并且是基于糖苷元和糖链的特殊和独特的化学结构。抗炎皂素的研究日益引起人们的兴趣。超过25%的关于这一主题的科学论文是在过去4年里发表的。毫无疑问,某些皂苷具有抗炎潜力,然而,大多数研究使用的是半纯化的皂苷混合物或总皂苷,结果是描述性的,缺乏对结构-功能关系的详细了解。迄今为止,还没有证据表明,细胞内的哪些分子是皂素的目标。据推测,皂苷的各种抗炎作用是基于特定的相互作用,这些相互作用只能归因于具有特定化学功能的皂苷亚群。我们将首先选择具有已知结构和描述的抗炎作用的市售皂苷,以确定主要细胞靶点并揭示结构-功能关系。特别是,我们想要证明皂苷和目标之间的相互作用如何导致细胞因子设备的变化。在确认单个皂苷在细胞培养中的抗炎作用后,我们将继续进行标记研究、结合实验、定位研究、抑制剂实验、膜实验和生物途径跟踪。具有相似行为的新皂苷的鉴定和结构阐明将用于完善和推广所观察到的分子机制。我们将通过MALDI和NMR技术确定重要的结构特征(糖苷元、糖残基组成、糖链、立体异构体构型)。如果成功,计划在接下来的一段时间内研究体内抗炎作用的分子机制。
英文摘要
The unique diversity of plant glycosides harbors a considerable potential to derive a natural drug. In the past, we focused on the identification of glycosylated triterpenoids as endosomal escape enhancers in targeted tumor therapies. We identified a particular saponin, SO1861, from Saponaria officinalis L. and demonstrated in cell culture that tumor-targeted toxins can become enhanced in their cell killing efficacy up to 2,500,000-fold, which resulted in a broadening of the therapeutic window in mice between 10-fold to 500-fold. The tumor regression across all mouse studies was about 90% and the required dose was only 2% of the dose used for a treatment without SO1861. The lower dose resulted in decreased side effects and reduced immunogenicity. We demonstrated that the augmentative effect relies on an enhanced transfer of the toxin moiety across the membrane of the endocytic vesicle into the cytosol. It is important to emphasize that this specific outcome of SO1861 occurs at concentrations that are far below the concentration required to trigger general saponin effects (such as hemolysis) and is based on the particular and unique chemical structure of the aglycone and sugar chains.Investigations of anti-inflammatory saponins are of increasing interest. More than 25% of scientific papers on this topic are published within the last 4 years. There is no doubt that certain saponins have an anti-inflammatory potential, however, most investigations applied semi-purified saponin mixtures or total saponins, the results are descriptive and detailed knowledge on structure–function relationships is missing. It has not been shown to date, which molecules inside the cell are the targets of the saponins. It is hypothesized that the various anti-inflammatory effects of saponins are based on specific interactions that can be attributed to only a defined subgroup of saponins with particular chemical functionalities. We will first select commercially available saponins with known structure and described anti-inflammatory effects to identify primary cellular targets and to reveal structure–function relationships. In particular, we want to demonstrate how interactions between saponins and targets result in changes in the cytokine equipment. After confirming the anti-inflammatory effects of single saponins in cell culture, we will continue with labeling studies, binding assays, localization studies, inhibitor experiments, membrane assays and tracking of biological pathways. Identification and structural elucidation of new saponins with similar behavior will then be used to refine and generalize the observed molecular mechanisms. We will determine important structural characteristics (aglycone, composition of sugar residues, sugar linkage, stereoisomer configurations) by MALDI and NMR techniques. If successful, it is planned in a following period to investigate the molecular mechanism of the anti-inflammatory effects in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of tumor-activated targeted toxins and their investigation in combination with glycosylated triterpenoids
-
批准号:168337608
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Hendrik Fuchs
-
依托单位:
Regulated intramembrane proteolysis of transferrin receptor 1 and the role of the released intracellular domain in singaling of iron metabolism
-
批准号:73952010
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Hendrik Fuchs
-
依托单位:
Development of a novel strategy for cancer therapy by combining chimeric adaptertoxins and triterpenoids investigated on mammary gland tumors.
-
批准号:30656140
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Hendrik Fuchs
-
依托单位:
Identifizierung und Charakterisierung der Arg-100-Transferrinrezeptor-Sheddingprotease
-
批准号:5220036
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:Professor Dr. Hendrik Fuchs
-
依托单位:
Structural precision meets bio-functionality: Virus-like delivery systems for genetic material
-
批准号:527477869
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Hendrik Fuchs
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
-
批准号:82372167
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:江继宏
-
依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
-
批准号:82372306
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:彭奕冰
-
依托单位:
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
-
批准号:82371140
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李姝娜
-
依托单位:
多孔Ti-MSNs@MGF+DX抗炎—成肌体系应用于颞下颌关节假体的作用和机制研究
-
批准号:82370984
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑吉驷
-
依托单位:
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
-
批准号:82371691
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张健
-
依托单位:
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
-
批准号:82372120
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮慧瞳
-
依托单位:
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
-
批准号:31970688
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:章海兵
-
依托单位:
炎症因子调控干眼病眼表黏蛋白表达的分子机制
-
批准号:81100636
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:王艳
-
依托单位:
TRAM基因选择性调控LPS失控性炎症反应的实验研究
-
批准号:81071588
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:陈力勇
-
依托单位: